SCHEMBL2992486

SCHEMBL2992486

COc1ccc(NC(=O)[C@H](C)NC(=O)O)cc1NS(=O)(=O)c1ccc(-c2ccc(C)o2)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 2/20 0.44
POLB P06746 1/20 0.44
TSHR P16473 1/20 0.44
ACLY P53396 8/20 0.43
LMNA P02545 3/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 1/20 0.42
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
IDH1 O75874 1/20 0.40
GAA P10253 1/20 0.40
ACACB O00763 1/20 0.40
ACACA Q13085 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2996213 1.00 GHSR (0.55) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL14398049 0.93 GHSR (0.56) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL13245976 0.93 GHSR (0.56) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL13245992 0.93 GHSR (0.56) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL13245980 0.90 GHSR (0.57) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL14398048 0.90 GHSR (0.57) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL4664239 0.90 GHSR (0.57) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL2985941 0.88 GHSR (0.53) GHSRSMN1; SMN2ALDH1A1POLBTSHR
SCHEMBL2985942 0.88 GHSR (0.53) GHSRALDH1A1POLBTSHRACLY
SCHEMBL2984160 0.88 GHSR (0.53) GHSRALDH1A1POLBTSHRACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR GHSR 1/4885SMN1; SMN2 2538/4885ALDH1A1 2521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.